Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent
- 1 February 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (2) , H547-H555
Abstract
Fibroblast growth factor-2 (FGF-2) is cardioprotective when added exogenously, stimulates cardiac myocyte proliferation, and is a mediator of tissue repair after injury. Furthermore, transgenic (TG) mice overexpressing FGF-2 in cardiac muscle demonstrate increased resistance to injury in an isolated heart model of ischemia-reperfusion. We investigated how increasing the endogenous FGF-2 levels in the heart affects the extent of myocardial damage induced by isoproterenol in vivo. Histopathological evaluation of hearts after intraperitoneal injection of isoproterenol yielded significantly higher scores for myocardial damage in FGF-2 TG lines compared with non-TG mice. After 1 day, FGF-2 TG mouse hearts displayed more cellular infiltration correlating with increased tissue damage. Immunostaining of non-TG and FGF-2 TG mouse hearts showed the presence of leukocytes in the infiltrate, including T cells expressing FGF receptor-1. Treatment of mice with T cell suppressors cyclosporin A and anti-CD3ε significantly decreased the level of myocardial injury observed after isoproterenol and equalized the histopathology scores in FGF-2 TG and non-TG hearts. These data demonstrate a direct T cell involvement in the response to isoproterenol-induced injury in vivo. Moreover, the findings indicate that the exacerbation of myocardial damage in FGF-2 TG mice was dependent on T cell infiltration, implicating FGF-2 in the inflammatory response seen in cardiac tissue after injury in vivo.Keywords
This publication has 54 references indexed in Scilit:
- Fibroblast Growth Factor-2 Stimulates Endothelial Nitric Oxide Synthase Expression and Inhibits Apoptosis by a Nitric Oxide-Dependent Pathway in Nb2 Lymphoma CellsEndocrinology, 2001
- Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen GenesHypertension, 2000
- Fibroblast growth factor-2 mediates pressure-induced hypertrophic responseJournal of Clinical Investigation, 1999
- FGF-2-induced Negative Inotropism and Cardioprotection are Inhibited by Chelerythrine: Involvement of Sarcolemmal Calcium-independent Protein Kinase CJournal of Molecular and Cellular Cardiology, 1998
- The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: a mini reviewInternational Journal of Cardiology, 1997
- QUANTITATING IMMUNOSUPPRESSIONTransplantation, 1996
- Wound healing following myocardial infarctionClinical Cardiology, 1996
- Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injuryMolecular and Cellular Biochemistry, 1995
- Mechanisms of Action of Cyclosporine: Considerations for the Treatment of Autoimmune DiseasesClinical Immunology and Immunopathology, 1993
- Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sitesExperimental Cell Research, 1990